Miscellanea and rarities

  • F. Dudley Hart


The central place of rheumatology within general (internal) medicine is reflected by the wide spectrum of rheumatic conditions arising as ‘co-diseases’ or ‘complications’ of essentially non-rheumatic disorders, e.g. malignant, haematological, and endocrine diseases.


Systemic Lupus Erythematosus Familial Mediterranean Fever Giant Cell Arteritis Rheumatic Fever Polymyalgia Rheumatica 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexanian, R. and Nadell, J. (1975) Oxymetholone treatment for sickle cell anaemia. Blood, 45, 769–77.PubMedGoogle Scholar
  2. Ball, A. P. (1982) Clinical use of penicillins. Lancet, ii, 197.CrossRefGoogle Scholar
  3. Barber, H. S. (1957) Myalgic syndrome with constitutional effects. Ann. Rheum. Dis., 16, 230.PubMedCrossRefGoogle Scholar
  4. Barzel, U. S. (1973) Polyarteritis nodosa and hypertension: treatment with corticoids with complete remission. N. Y. State J. Med., 63, 2263.Google Scholar
  5. Belch, J. J. F., Newman, P., Drury, J. K., McKenzie, F., Capell, H., Lieberman, P., Forber, C. D. and Prentice, C. R. N. (1983) Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud’s syndrome. Lancet, i, 313–15.CrossRefGoogle Scholar
  6. Biggs, R. (ed.) (1976) The Treatment of Haemophilia A and B and Von Willebrand’s Disease, 2nd edn, Blackwell, Oxford.Google Scholar
  7. Bloch, K. J., Buchanan, W. W., Wohl, M. T. and Bunim, J. J. (1965) Sjøgren’s syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine (Baltimore), 44, 187.CrossRefGoogle Scholar
  8. Bremner, W. J. and Paulsen, C. A. (1976) Colchicine and testicular function in man. N. Engl. J. Med., 294, 1384–5.PubMedCrossRefGoogle Scholar
  9. Bunch, T. W. (1981) Prednisone and azathioprine for polymyositis. Arthr. Rheum., 24, 45.CrossRefGoogle Scholar
  10. Bunch, T. W., Worthington, J. W., Commbs, J. J., Duane, M., Ilstrup, M. and Engel, A. G. (1980) Azathioprine with prednisone for polymyositis. Ann. Intern. Med., 92, 365.PubMedCrossRefGoogle Scholar
  11. Cade, R., Spooner, G., Schlein, E., Pickering, M. et al. (1973) Comparison of azathioprine, prednisone and heparin alone or combined in treating lupus nephritis. Nephron, 10, 37.PubMedCrossRefGoogle Scholar
  12. Camerini, F., Alberti, E., Klugmann, S. and Salvi, A. (1980) Primary pulmonary hypertension: effects of nifedipine. Br. Heart J., 44, 352–6.PubMedCrossRefGoogle Scholar
  13. Crisp, A. J. (1981) Pizotifen to prevent side effects of calcitonin. Lancet, i, 775.CrossRefGoogle Scholar
  14. De Ceular, K., Gruber, C., Hayes, R. and Sarjeant, G. R. (1982) Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet, ii, 229–31.CrossRefGoogle Scholar
  15. Donadio, J. V., Holley, K. E., Wagener, R. D., Ferguson, R. H. and McDuffie, F. C. (1974) Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Arthr. Rheum., 17, 573.CrossRefGoogle Scholar
  16. Douglas Smith, C. and McKendry, R. J. R. (1982) Controlled trial of nifedipine in the treatment of Raynaud’s phenomenon. Lancet, ii, 1299–301.CrossRefGoogle Scholar
  17. Dowd, P. M., Martin, M. F. R. and Cooke, E. D. (1982) Treatment of Raynaud’s phenomenon by intravenous infusion of prostacyclin (PGI2). Br. J. Dermatol., 106, 81–9.PubMedCrossRefGoogle Scholar
  18. Dubois, E. L. (1974) Lupus Erythematosus. University of Southern California Press, Los Angeles.Google Scholar
  19. Duthie, R. B., Matthews, J. M., Rizza, C. H. and Steel, W. M. (1972) The Management of Musculo-skeletal Problems in the Haemophilias, Blackwell, Oxford.Google Scholar
  20. Eliakim, M. and Licht, A. (1973) Colchicine—aspirin for recurrent polyserositis (F.M.F.). Lancet, ii, 1333.CrossRefGoogle Scholar
  21. Franks, A. G. (1982) Topical glyceryl trinitrate as adjunctive therapy in Raynaud’s disease. Lancet, i, 76.CrossRefGoogle Scholar
  22. Goldfinger, S. E. (1972) Colchicine for F.M.F. N. Engl. J. Med., 287, 1302.PubMedGoogle Scholar
  23. Gordon, I. (1960) Polymyalgia rheumatica. Q. J. Med., 29, 473.Google Scholar
  24. Gratwick, G. (1982) Progressive systemic sclerosis in Drug Treatment of the Rheumatic Diseases (ed. F. D. Hart), 2nd edn, Adis Press, Australasia, p. 172.Google Scholar
  25. Hart, F. D. (1982) Drug Treatment of the Rheumatic Diseases, 2nd edn, Adis Press, Australasia.Google Scholar
  26. Hench, P. S. and Rosenberg, E. F. (1944) Palindromic rheumatism. Arch. Intern. Med., 73, 293–321.CrossRefGoogle Scholar
  27. Henderson, J. W. (1950) Keratoconjunctivitis sicca — a review with a survey of 121 additional cases. Am. J. Ophthalmol., 33, 197.PubMedGoogle Scholar
  28. Huskisson, E. C. (1976) Treatment of palindromic rheumatism with d-penicillamine. Br. Med. J., 2, 979.PubMedCrossRefGoogle Scholar
  29. Huskisson, E. C. (1982) Less common arthropathies in Drug Treatment of the Rheumatic Diseases (ed F. D. Hart), 2nd edn, Adis Press, Australasia.Google Scholar
  30. Huskisson, E. C. and Hart, F. D. (1978) Joint Disease, 3rd edn, Wright, Bristol, p. 32.Google Scholar
  31. Isaacs, W. A. and Hayhoe, F. G. J. (1967) Steroid hormones in sickle-cell disease. Nature, 215, 1139–42.PubMedCrossRefGoogle Scholar
  32. Johnsson, S. and Leonhardt, T. (1957) Polyarteritis nodosa and its treatment with ACTH or cortisone. Acta Med. Scand., 157, 479.PubMedCrossRefGoogle Scholar
  33. Kagen, L. (1982) Dermatomyositis and Polymyositis in Drug Treatment of the Rheumatic Diseases (ed F. D. Hart), 2nd edn, Adis Press, Australasia, pp. 166–71.Google Scholar
  34. Kahan, A., Weber, S., Amor, B. and Menkes, C. J. (1983) Epoprostenol (prostacycline) infusion in patients with Raynaud’s syndrome (Letter). Lancet, i, 538.CrossRefGoogle Scholar
  35. Kellgren, J. H., Ball, J., Fairbrother, R. W. and Barnes, K. L. (1958) Suppurative arthritis complicating rheumatoid arthritis. Br. Med. J., 1, 1193–200.PubMedCrossRefGoogle Scholar
  36. Kennerly, D. (1983) Raynaud’s disease and prostacycline (Letter). Ann. Intern. Med., 98, 258.PubMedCrossRefGoogle Scholar
  37. Kisker, C. T. and Burke, C. (1970) Double blind studies in the use of steroids in the treatment of acute haemarthrosis in patients with haemophilia. N. Engl. J. Med., 282, 639–42.PubMedCrossRefGoogle Scholar
  38. Kogstad, O. A. (1965) Polymyalgia rheumatica and its relation to arteritis temporalis. Acta Med. Scand., 178, 591.PubMedCrossRefGoogle Scholar
  39. Leading Article (1975) Br. Med. J., 3, 60.CrossRefGoogle Scholar
  40. LeRoy, E. C. (1981) Scleroderma (systemic sclerosis), in Textbook of Rheumatology (eds W. N. Kelley, E. D. Harris, S. Ruddy and C. B. Sledge), Saunders, Philadelphia, London, Toronto, p. 1211.Google Scholar
  41. Lightfoot, R. W. and Hughes, G. R. V. (1976) Significance of persisting serologic abnormalities in SLE. Arthr. Rheum., 19, 837.CrossRefGoogle Scholar
  42. Mattingley, S. (1966) Palindromic rheumatism. Ann. Rheum. Dis., 25, 307–17.Google Scholar
  43. Mattingley, S., Jones, D. W., Robinson, W. M., Williams, R. A. and Dunn, E. C. (1981) Palindromic rheumatism. J. R. Coll. Phys., 15, 119.Google Scholar
  44. Moskowitz, R. W., Baggenstoss, A. H. and Slocumb, C. H. (1963) Histopathologic classification of periarteritis nodosa: a study of 56 cases confirmed at necroscopy. Proc. Mayo Clinic, 38, 345.Google Scholar
  45. Ocken, S., Reinitz, E. and Strom, J. (1983) Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis. Arthr. Rheum., 26, 794–6.CrossRefGoogle Scholar
  46. Pearson, C. M. (1979) Polymyositis and dermatomyositis in Arthritis and Allied Conditions (ed. D. J. McCarty), 9th edn, Lea and Febiger, Philadelphia, pp. 742–61.Google Scholar
  47. Rich, R. R. and Johnson, J. S. (1973) Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthr. Rheum., 16, 1–9.CrossRefGoogle Scholar
  48. Rodeheffer, R. J., Rommer, J. A., Wigley, F. and Smith, C. R. (1983) Controlled double-blind trial of nifedipine in the treatment of Raynaud’s phenomenon. N. Engl. J. Med., 308, 880–3.PubMedCrossRefGoogle Scholar
  49. Rodnan, G. P. (1979) Progressive systemic sclerosis (scleroderma) in Arthritis and Allied Conditions (ed D. J. McCarty), 9th edn, Lea and Febiger, Philadelphia, p. 762.Google Scholar
  50. Rustin, M. H. A., Cooke, E. D., Bowcock, S. A. and Kirby, J. D. T. (1983) Nifedipine for Raynaud’s phenomenon (Letter). Lancet, i, 130.CrossRefGoogle Scholar
  51. Shick, R. M. (1958) Periarteritis nodosa and temporal arteritis: treatment with adrenal corticosteroids. Med. Clinics N. Am., 42, 959.Google Scholar
  52. Smith, R. (1982) Modern treatment of Paget’s disease of bone. Prescribers’ J., 22, 25–31.Google Scholar
  53. Sturrock, R. D., Cowden, E. A., Howie, E., Grennan, D. M. and Buchanan, W. W. (1975) The forgotten nodule: complications of sacral nodules in rheumatoid arthritis. Br. Med. J., 4, 92–3.PubMedCrossRefGoogle Scholar
  54. Talal, N. (1966) Sjøgren’s syndrome. Bull. Rheum. Dis., 16, 404.PubMedGoogle Scholar
  55. Thomas, E. D., Buckner, C. D., Sanders, J. E., Papayannopoulou, T., Borgna-Pignatti, C., De Stefano, P., Sullivan, K. M., Clift, R. A. and Storb, R. (1982) Marrow transplantation for thalassaemia. Lancet, ii, 227–9.CrossRefGoogle Scholar
  56. Wadman, B. and Werner, I. (1967) Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica. Lancet, i, 597.CrossRefGoogle Scholar
  57. William, M. H., Sheldon, P. J. H. S., Torrigiani, G., Eisen, V. and Mattingley, S. (1971) Palindromic rheumatism. Ann. Rheum. Dis., 30, 375–80.CrossRefGoogle Scholar
  58. Winkelmann, R. K., Merwin, C. F. and Brunsting, L. A. (1961) Antimalarial therapy of lupus erythematosus. Ann. Intern. Med., 55, 772.PubMedCrossRefGoogle Scholar
  59. Wolff, S. M., Fauci, A. S., Horn, R. G. et al. (1974) Wegener’s granulomatosis. Ann. Intern. Med., 81, 513.PubMedCrossRefGoogle Scholar

Copyright information

© J. M. H. Moll, H. A. Bird and A. Rushton 1986

Authors and Affiliations

  • F. Dudley Hart

There are no affiliations available

Personalised recommendations